Specialty Medical Injectable Drug program updates
AI Summary
UnitedHealthcare has published updates to their Specialty Medical Injectable Drug Program for December 2025, affecting specialty drugs that require review at launch and updating program requirements and policies. Healthcare providers need to access the Medical Benefit Specialty Drug Update Bulletin for complete details on which drugs are newly added to review requirements.
Action Required
Immediately: Access and review the Medical Benefit Specialty Drug Update Bulletin on the UnitedHealthcare Provider Portal to identify newly added specialty injectable drugs requiring review at launch. Update prior authorization workflows and staff training for affected specialty drugs. Monitor patient treatment plans that may involve newly regulated specialty injectables to ensure compliance with updated program requirements.
Plan Types
All Plans
Specialties
oncology, rheumatology, neurology, gastroenterology, endocrinology, dermatology, ophthalmology